Monday - August 3, 2026
From Calvin to the Cutting-Edge of Drug Development
July 31, 2026
GRAND RAPIDS, Michigan, July 31 -- Calvin University posted the following news:

* * *

From Calvin to the Cutting-Edge of Drug Development

*

Kyle Timmer '20 spends his days helping turn cutting-edge drug discoveries into treatments that can reach patients. As a senior scientist for AbbVie, a pharmaceutical company based in Chicago, his role sits at the intersection of R&D (research and development) and commercial-scale manufacturing.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products